Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon.
Alothman AF, Althaqafi AO, Matar MJ, Moghnieh R, Alenazi TH, Farahat FM, Corman S, Solem CT, Raghubir N, Macahilig C, Charbonneau C, Stephens JM. Alothman AF, et al. Among authors: charbonneau c. Infect Drug Resist. 2017 Feb 2;10:35-41. doi: 10.2147/IDR.S97413. eCollection 2017. Infect Drug Resist. 2017. PMID: 28203095 Free PMC article.
Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
Lawson W, Nathwani D, Eckmann C, Corman S, Stephens J, Solem C, Macahilig C, Li J, Baillon-Plot N, Charbonneau C, Haider S. Lawson W, et al. Among authors: charbonneau c. Clin Microbiol Infect. 2015 Sep;21 Suppl 2:S40-6. doi: 10.1016/j.cmi.2015.05.030. Epub 2015 Jul 20. Clin Microbiol Infect. 2015. PMID: 26206621 Free article.
Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria.
Eckmann C, Lawson W, Nathwani D, Solem CT, Stephens JM, Macahilig C, Simoneau D, Hajek P, Charbonneau C, Chambers R, Li JZ, Haider S. Eckmann C, et al. Among authors: charbonneau c. Int J Antimicrob Agents. 2014 Jul;44(1):56-64. doi: 10.1016/j.ijantimicag.2014.04.007. Epub 2014 May 16. Int J Antimicrob Agents. 2014. PMID: 24928311 Free article.
Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
Eckmann C, Nathwani D, Lawson W, Corman S, Solem C, Stephens J, Macahilig C, Li J, Charbonneau C, Baillon-Plot N, Haider S. Eckmann C, et al. Among authors: charbonneau c. Clin Microbiol Infect. 2015 Sep;21 Suppl 2:S33-9. doi: 10.1016/j.cmi.2015.01.011. Epub 2015 Jul 18. Clin Microbiol Infect. 2015. PMID: 26198370 Free article.
Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections.
Dryden M, Baguneid M, Eckmann C, Corman S, Stephens J, Solem C, Li J, Charbonneau C, Baillon-Plot N, Haider S. Dryden M, et al. Among authors: charbonneau c. Clin Microbiol Infect. 2015 Sep;21 Suppl 2:S27-32. doi: 10.1016/j.cmi.2015.03.024. Epub 2015 Jul 18. Clin Microbiol Infect. 2015. PMID: 26198368 Free article. Review.
Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico.
Morfín-Otero R, Alvarado-Ibarra M, Rodriguez-Noriega E, Resendiz-Sanchez J, Patel DA, Stephens JM, Di Fusco M, Mendoza CF, Charbonneau C. Morfín-Otero R, et al. Among authors: charbonneau c. Clinicoecon Outcomes Res. 2018 Sep 6;10:511-520. doi: 10.2147/CEOR.S157642. eCollection 2018. Clinicoecon Outcomes Res. 2018. PMID: 30233223 Free PMC article.
Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review.
Nathwani D, Varghese D, Stephens J, Ansari W, Martin S, Charbonneau C. Nathwani D, et al. Among authors: charbonneau c. Antimicrob Resist Infect Control. 2019 Feb 12;8:35. doi: 10.1186/s13756-019-0471-0. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 30805182 Free PMC article.
Implementing criteria-based early switch/early discharge programmes: a European perspective.
Nathwani D, Lawson W, Dryden M, Stephens J, Corman S, Solem C, Li J, Charbonneau C, Baillon-Plot N, Haider S, Eckmann C. Nathwani D, et al. Among authors: charbonneau c. Clin Microbiol Infect. 2015 Sep;21 Suppl 2:S47-55. doi: 10.1016/j.cmi.2015.03.023. Epub 2015 Jul 18. Clin Microbiol Infect. 2015. PMID: 26198369 Free article. Review.
Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain.
Ostermann H, Solano C, Jarque I, Garcia-Vidal C, Gao X, Barrueta JA, De Salas-Cansado M, Stephens J, Xue M, Weber B, Charbonneau C. Ostermann H, et al. Among authors: charbonneau c. BMC Pharmacol Toxicol. 2014 Sep 24;15:52. doi: 10.1186/2050-6511-15-52. BMC Pharmacol Toxicol. 2014. PMID: 25253630 Free PMC article.
126 results